Andrew J. Krouse
Founder at Cavion, Inc.
Andrew J. Krouse active positions
| Companies | Position | Start | End |
|---|---|---|---|
Cavion, Inc.
 Cavion, Inc. Pharmaceuticals: MajorHealth Technology Cavion, Inc. engages in development of pharmaceuticals products. It produces oncology drugs to treat solid tumors that selectively inhibits the t-type calcium channel. The company was founded by Andrew J. Krouse, Lloyd S. Gray, and Timothy L. Macdonald in 2005 and is headquartered in Charlottesville, VA. | Director/Board Member | - | - |
| Chief Executive Officer | 2004-12-31 | - | |
| Founder | 2009-08-02 | - | |
| President | 2004-12-31 | - | |
| Chairman | 2004-12-31 | 2010-05-02 | |
| The Virginia Bioscience Foundation | Director/Board Member | 2017-12-31 | - |
Slate Bio, Inc.
 Slate Bio, Inc. BiotechnologyHealth Technology Slate Bio, Inc. is a pre-clinical stage biotechnology company that focuses on developing therapies to restore the body's natural immunological response in various diseases. The company is based in Charlottesville, VA. The company's lead compound is a bifunctional IL233 cytokine that augments Tregs and expands tissue resident Tregs. The CEO of the company is Andrew J. Krouse. | Chief Executive Officer | - | - |
| President | - | - | |
GenEp, Inc.
 GenEp, Inc. BiotechnologyHealth Technology GenEp, Inc. is a pre-clinical stage biotechnology company that aims to create therapies for rare genetic epilepsies and other treatment-resistant epilepsies. The company is based in Charlottesville, VA and was founded in 2021. The company is privately held and is based on intellectual property assets licensed from the University of Virginia. The CEO is Andrew J. Krouse. | Chief Executive Officer | - | - |
| President | - | - |
Career history of Andrew J. Krouse
Former positions of Andrew J. Krouse
| Companies | Position | Start | End |
|---|---|---|---|
| Darden School Foundation | Corporate Officer/Principal | - | - |
Virginia Biotechnology Association
 Virginia Biotechnology Association Miscellaneous Commercial ServicesCommercial Services Virginia Biotechnology Association promotes the biotechnology industry. The private company is based in Richmond, VA. The company was founded in 1992 by Terry R. Woodworth. John L. Newby has been the CEO of the company since 2019. | Director/Board Member | - | 2017-08-29 |
| Chairman | 2017-08-29 | - | |
| Treasurer | - | - | |
| University of Virginia | Corporate Officer/Principal | - | - |
Training of Andrew J. Krouse
| University of Maryland | Undergraduate Degree |
| Georgetown University | Graduate Degree |
Statistics
International
| United States | 10 |
Operational
| Director/Board Member | 3 |
| Chief Executive Officer | 3 |
| President | 3 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 4 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 6 |
|---|---|
Cavion, Inc.
Cavion, Inc. Pharmaceuticals: MajorHealth Technology Cavion, Inc. engages in development of pharmaceuticals products. It produces oncology drugs to treat solid tumors that selectively inhibits the t-type calcium channel. The company was founded by Andrew J. Krouse, Lloyd S. Gray, and Timothy L. Macdonald in 2005 and is headquartered in Charlottesville, VA. | Health Technology |
| Darden School Foundation | |
Virginia Biotechnology Association
Virginia Biotechnology Association Miscellaneous Commercial ServicesCommercial Services Virginia Biotechnology Association promotes the biotechnology industry. The private company is based in Richmond, VA. The company was founded in 1992 by Terry R. Woodworth. John L. Newby has been the CEO of the company since 2019. | Commercial Services |
| The Virginia Bioscience Foundation | |
Slate Bio, Inc.
Slate Bio, Inc. BiotechnologyHealth Technology Slate Bio, Inc. is a pre-clinical stage biotechnology company that focuses on developing therapies to restore the body's natural immunological response in various diseases. The company is based in Charlottesville, VA. The company's lead compound is a bifunctional IL233 cytokine that augments Tregs and expands tissue resident Tregs. The CEO of the company is Andrew J. Krouse. | Health Technology |
GenEp, Inc.
GenEp, Inc. BiotechnologyHealth Technology GenEp, Inc. is a pre-clinical stage biotechnology company that aims to create therapies for rare genetic epilepsies and other treatment-resistant epilepsies. The company is based in Charlottesville, VA and was founded in 2021. The company is privately held and is based on intellectual property assets licensed from the University of Virginia. The CEO is Andrew J. Krouse. | Health Technology |
- Stock Market
- Insiders
- Andrew J. Krouse
- Experience
